(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
4 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 8.18%
@ $1.778
जारी किया गया: 14 Feb 2024 @ 20:00
वापसी: 15.29%
पिछला सिग्नल: Feb 13 - 00:57
पिछला सिग्नल:
वापसी: -3.36 %
Live Chart Being Loaded With Signals
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders...
Stats | |
---|---|
आज की मात्रा | 1.17M |
औसत मात्रा | 1.60M |
बाजार मूल्य | 343.20M |
EPS | $0 ( 2024-03-29 ) |
अगली कमाई की तारीख | ( $-0.200 ) 2024-05-09 |
Last Dividend | $6.00 ( 2018-08-27 ) |
Next Dividend | $0 ( N/A ) |
P/E | -8.20 |
ATR14 | $0.00300 (0.15%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-15 | Apeiron Investment Group Ltd. | Buy | 147 950 | Convertible Notes |
2024-04-15 | Apeiron Investment Group Ltd. | Sell | 147 950 | Convertible Notes |
2024-04-02 | Johnson Anne Nagengast | Sell | 27 410 | Common Shares |
2024-04-02 | Rao Srinivas | Sell | 61 640 | Common Shares |
2024-04-02 | Kirpekar Sahil | Sell | 35 801 | Common Shares |
INSIDER POWER |
---|
56.53 |
Last 90 transactions |
Buy: 18 737 833 | Sell: 13 770 797 |
मात्रा सहसंबंध
ATA Inc. सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध | |
---|---|
LLNW | 0.94 |
PAVM | 0.928 |
SVOK | 0.916 |
IMCC | 0.913 |
NVTSW | 0.913 |
SWAV | 0.912 |
QTEK | 0.912 |
RDHL | 0.911 |
QAT | 0.91 |
NKTX | 0.91 |
10 सबसे अधिक नकारात्मक सहसंबंध | |
---|---|
ITMR | -0.949 |
AVEO | -0.939 |
GAINM | -0.933 |
XOMAO | -0.931 |
DVCR | -0.925 |
ALXN | -0.923 |
PPD | -0.923 |
GLLI | -0.923 |
MLCO | -0.923 |
ACAB | -0.922 |
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
ATA Inc. सहसंबंध - मुद्रा/वस्त्र
ATA Inc. वित्तीय
Annual | 2023 |
राजस्व: | $314 000 |
सकल लाभ: | $-5 000.00 (-1.59 %) |
EPS: | $-0.250 |
FY | 2023 |
राजस्व: | $314 000 |
सकल लाभ: | $-5 000.00 (-1.59 %) |
EPS: | $-0.250 |
FY | 2022 |
राजस्व: | $233 000 |
सकल लाभ: | $65 000.00 (27.90 %) |
EPS: | $-0.910 |
FY | 2021 |
राजस्व: | $0.00 |
सकल लाभ: | $0.00 (0.00 %) |
EPS: | $-1.100 |
Financial Reports:
No articles found.
ATA Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.430 | 2011-06-28 |
Last Dividend | $6.00 | 2018-08-27 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | $7.36 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.25 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Royal | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -128.70 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.138 | 1.200 | -4.59 | -5.51 | [0 - 0.3] |
returnOnEquityTTM | -0.920 | 1.500 | -10.00 | -10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 9.22 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 7.78 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 2.24 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0528 | -1.500 | 9.12 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -46.97 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.524 | 2.00 | -0.175 | -0.349 | [0 - 30] |
freeCashFlowPerShareTTM | -0.528 | 2.00 | -0.264 | -0.528 | [0 - 20] |
debtEquityRatioTTM | 0.0637 | -1.500 | 9.75 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | -0.710 | 1.000 | -10.00 | -10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | -397.42 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -5.38 | 1.000 | -10.00 | -10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.00107 | 0.800 | -3.33 | -2.66 | [0.5 - 2] |
Total Score | -2.40 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -8.06 | 1.000 | -0.915 | 0 | [1 - 100] |
returnOnEquityTTM | -0.920 | 2.50 | -7.29 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.528 | 2.00 | -0.176 | -0.528 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.524 | 2.00 | -0.175 | -0.349 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0846 | 1.500 | -3.90 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -265.15 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -2.75 |
ATA Inc.
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA-B receptor modulator to treat cognitive impairment associated with schizophrenia; DMX-1002, an oral formulation of ibogaine for treating opioid use disorder (OUD); GRX-917, an oral formulation of a deuterated version of etifoxine for the generalized anxiety disorder treatment; and NN-101, a novel intranasal formulation of N-acetylcysteine to treat mild traumatic brain injuries. Its therapeutic candidates also comprise VLS-01, a formulation of N,N-dimethyltryptamine for treating TRD; EMP-01, an oral formulation of an 3,4-methyl enedioxy methamphetamine for the treatment of post-traumatic stress disorder; RLS-01, a formulation of Salvinorin A for TRD; KUR-101, an oral formulation of deuterated mitragynine to treat OUD; and DMX-1001, an oral formulation of noribogaine for the treatment of OUD. The company was formerly known as Adripa Holding B.V. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं